Cannabis based drug is licensed for spasticity in patients with MS.
Kmietowicz
Zosia
Z
D002185:Cannabidiol; D002186:Cannabinoids / Q000627:therapeutic use*; D002188:Cannabis; D013759:Dronabinol; D017277:Drug Approval; D004338:Drug Combinations; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D009128:Muscle Spasticity / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use*; D010936:Plant Extracts / Q000627:therapeutic use*
D002186:Cannabinoids; D004338:Drug Combinations; D010276:Parasympatholytics; D010936:Plant Extracts; D002185:Cannabidiol; D013759:Dronabinol; C587251:nabiximols